back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-06-10 16:14 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-271,977.75
-29,403 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 16:13 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$227,285
+29,403 vol $7.73 each |
39,794 | |
| Filed 2026-06-10 16:11 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-227,285.19
-29,403 vol $7.73 each |
1,414 | |
| Filed 2026-06-10 16:03 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-47,443.25
-5,129 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 16:02 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$36,005
+5,129 vol $7.02 each |
15,520 | |
| Filed 2026-06-10 16:00 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-36,005.58
-5,129 vol $7.02 each |
30,817 | |
| Filed 2026-06-10 15:56 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,808.25
-1,709 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 15:55 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$11,997
+1,709 vol $7.02 each |
12,100 | |
| Filed 2026-06-10 15:54 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-11,997.18
-1,709 vol $7.02 each |
35,946 | |
| Filed 2026-06-10 15:50 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,360.75
-4,039 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 15:48 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,103
+4,039 vol $5.72 each |
14,430 | |
| Filed 2026-06-10 15:47 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-23,103.08
-4,039 vol $5.72 each |
37,655 | |
| Filed 2026-06-10 15:44 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,360.75
-4,039 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 15:42 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,103
+4,039 vol $5.72 each |
14,430 | |
| Filed 2026-06-10 15:40 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-23,103.08
-4,039 vol $5.72 each |
41,694 | |
| Filed 2026-06-10 15:36 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-40,607.50
-4,390 vol $9.25 each |
10,391 | |
| Filed 2026-06-10 15:33 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$27,261
+4,390 vol $6.21 each |
14,781 | |
| Filed 2026-06-10 15:28 Tx date 2026-06-10 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-27,261.90
-4,390 vol $6.21 each |
45,733 | |
| Filed 2026-03-27 18:38 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$37,491
+5,951 vol $6.30 each |
17,225 | |
| Filed 2026-03-27 18:36 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$74,982
+11,902 vol $6.30 each |
34,451 | |
| Filed 2026-03-27 18:33 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,364
+16,407 vol $6.30 each |
50,123 | |
| Filed 2026-03-27 18:31 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$29,402
+4,587 vol $6.41 each |
10,391 | |
| Filed 2026-03-27 18:28 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-18,563.64
-4,181 vol $4.44 each |
22,549 | |
| Filed 2026-03-27 18:26 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-18,563.64
-4,181 vol $4.44 each |
11,274 | |
| Filed 2025-04-04 19:25 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,973
+2,751 vol $6.17 each |
5,804 | |
| Filed 2025-04-04 19:23 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-17,547.28
-3,368 vol $5.21 each |
26,730 | |
| Filed 2025-04-04 19:21 Tx date 2025-04-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-17,547.28
-3,368 vol $5.21 each |
15,455 | |
| Filed 2025-03-29 16:36 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$35,558
+5,726 vol $6.21 each |
18,823 | |
| Filed 2025-03-29 16:35 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$71,123
+11,453 vol $6.21 each |
30,098 | |
| Filed 2025-03-29 16:34 Tx date 2025-03-24 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$109,053
+17,561 vol $6.21 each |
33,716 | |
| Filed 2024-08-26 14:58 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,053 | ||
| Filed 2024-08-26 14:53 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
7,549 | ||
| Filed 2024-08-26 14:53 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
7,549 | ||
| Filed 2024-04-16 18:52 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:51 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-25 14:55 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$92,406
+16,155 vol $5.72 each |
16,155 | |
| Filed 2024-04-16 18:50 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$91,695
+16,087 vol $5.70 each |
||
| Filed 2024-04-16 18:53 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$31,623
+5,548 vol $5.70 each |
5,548 | |
| Filed 2024-04-16 18:52 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:51 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$63,247
+11,096 vol $5.70 each |
11,096 | |
| Filed 2024-04-16 18:51 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-04-16 18:50 Tx date 2024-04-12 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$91,695
+16,087 vol $5.70 each |
16,087 | |
| Filed 2024-04-16 18:50 Tx date 2024-01-01 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|